14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 21, 2024 Buy 160 115 Minai-azary Jennifer Lynn Stock Option (right to buy)
Mar 21, 2024 Buy 153 515 Levit Alex C. Stock Option (right to buy)
Mar 21, 2024 Buy 291 402 Lehr Martin A. Stock Option (right to buy)
May 31, 2023 Buy 25 000 Kantoff Philip W. Stock Option (right to buy)
May 31, 2023 Buy 25 000 West Linda Stock Option (right to buy)
May 31, 2023 Buy 25 000 Stacey Jennifer Evans Stock Option (right to buy)
May 31, 2023 Buy 50 000 Berman Richard J Stock Option (right to buy)
Feb 21, 2023 Buy 5 823 Lehr Martin A. Common Stock
Feb 13, 2023 Buy 151 505 Levit Alex C. Stock Option (right to buy)
Feb 13, 2023 Buy 287 544 Lehr Martin A. Stock Option (right to buy)
Feb 13, 2023 Buy 158 001 Minai-azary Jennifer Lynn Stock Option (right to buy)
Feb 13, 2023 Buy 5 606 Lehr Martin A. Common Stock
Feb 06, 2023 Buy 5 040 Lehr Martin A. Common Stock
Jan 30, 2023 Buy 7 027 Lehr Martin A. Common Stock
Jan 23, 2023 Buy 6 839 Lehr Martin A. Common Stock
Jan 17, 2023 Buy 6 783 Lehr Martin A. Common Stock
Dec 16, 2022 Buy 25 000 Minai-azary Jennifer Lynn Common Stock
Dec 16, 2022 Buy 20 000 Lehr Martin A. Common Stock
Dec 09, 2022 Buy 6 000 Levit Alex C. Common Stock
Aug 19, 2022 Buy 13 000 Lehr Martin A. Common Stock
Aug 17, 2022 Buy 15 000 Minai-azary Jennifer Lynn Common Stock
Aug 16, 2022 Buy 10 000 Sahmoud Tarek Common Stock
Aug 12, 2022 Buy 25 000 Sahmoud Tarek Stock Option (right to buy)
Jun 02, 2022 Buy 25 000 West Linda Stock Option (right to buy)
Jun 02, 2022 Buy 25 000 West Linda Stock Option (right to buy)
Jun 02, 2022 Buy 25 000 Kantoff Philip W. Stock Option (right to buy)
Jun 02, 2022 Buy 50 000 Berman Richard J Stock Option (right to buy)
Jun 02, 2022 Buy 50 000 Berman Richard J Stock Option (right to buy)
Jun 02, 2022 Buy 25 000 Stacey Jennifer Evans Stock Option (right to buy)
Jun 02, 2022 Buy 25 000 Stacey Jennifer Evans Stock Option (right to buy)
Feb 25, 2022 Buy 107 870 Levit Alex C. Stock Option (right to buy)
Feb 25, 2022 Buy 112 470 Minai-azary Jennifer Lynn Stock Option (right to buy)
Feb 25, 2022 Buy 254 300 Lehr Martin A. Stock Option (right to buy)
Feb 15, 2022 Buy 29 223 Dick Evan G. Stock Option (right to buy)
Feb 15, 2022 Buy 8 000 Rencher William F. Stock Option (right to buy)
Dec 16, 2021 Buy 13 000 Lehr Martin A. Common Stock
Nov 01, 2021 Buy 52 753 Minai-azary Jennifer Lynn Stock Option (right to buy)
Nov 01, 2021 Buy 0 Minai-azary Jennifer Lynn
Oct 22, 2021 Buy 10 000 Lehr Martin A. Common Stock
Oct 22, 2021 Buy 586 475 Lehr Martin A. Common Stock
Oct 22, 2021 Buy 210 715 Lehr Martin A. Common Stock
Oct 22, 2021 Sell 210 715 Lehr Martin A. Series A Preferred Stock
Oct 22, 2021 Sell 586 475 Lehr Martin A. Series Seed Preferred Stock
Oct 22, 2021 Buy 52 680 Lehr Martin A. Warrant (right to buy)
Oct 22, 2021 Buy 52 680 Lehr Martin A. Common Stock
Oct 22, 2021 Buy 26 587 Dick Evan G. Common Stock
Oct 22, 2021 Sell 26 587 Dick Evan G. Series Seed Preferred Stock
Oct 22, 2021 Buy 3 000 Levit Alex C. Common Stock
Oct 22, 2021 Buy 586 476 Lehr Martin A. Common Stock
Oct 22, 2021 Buy 210 722 Lehr Martin A. Common Stock
Oct 22, 2021 Buy 10 000 Lehr Martin A. Common Stock
Oct 22, 2021 Buy 52 680 Lehr Martin A. Common Stock
Oct 22, 2021 Sell 586 476 Lehr Martin A. Series Seed Preferred Stock
Oct 22, 2021 Buy 52 680 Lehr Martin A. Warrant (right to buy)
Oct 22, 2021 Sell 210 722 Lehr Martin A. Series A Preferred Stock
Oct 22, 2021 Buy 26 587 Dick Evan G. Common Stock
Oct 22, 2021 Sell 26 587 Dick Evan G. Series Seed Preferred Stock
Oct 19, 2021 Sell 0 Dick Evan G. Common Stock
Oct 19, 2021 Sell 416 Rencher William F. Stock Option (right to buy)
Oct 19, 2021 Buy 0 Lehr Martin A. Common Stock
Oct 19, 2021 Buy 210 722 Lehr Martin A. Series A Preferred Stock
Oct 19, 2021 Buy 586 476 Lehr Martin A. Series Seed Preferred Stock
Oct 19, 2021 Buy 281 354 Lehr Martin A. Stock Option (right to buy)
Oct 19, 2021 Buy 52 754 Levit Alex C. Stock Option (right to buy)
Oct 19, 2021 Buy 833 Levit Alex C. Stock Option (right to buy)
Oct 19, 2021 Buy 0 Sahmoud Tarek
Oct 19, 2021 Buy 0 Rencher William F. Common Stock
Oct 19, 2021 Buy 12 333 Rencher William F. Stock Option (right to buy)
Oct 19, 2021 Buy 0 Dick Evan G. Common Stock
Oct 19, 2021 Buy 26 587 Dick Evan G. Series Seed Preferred Stock
Oct 19, 2021 Buy 1 250 Dick Evan G. Stock Option (right to buy)
Oct 19, 2021 Buy 30 000 Berman Richard J Stock Option (right to buy)
Oct 19, 2021 Buy 15 000 Stacey Jennifer Evans Stock Option (right to buy)
Oct 19, 2021 Buy 0 Kantoff Philip W. Common Stock
Oct 19, 2021 Buy 15 000 Kantoff Philip W. Stock Option (right to buy)
Oct 19, 2021 Buy 15 000 West Linda Stock Option (right to buy)
Dec 20, 2020 Buy 52 680 Lehr Martin A. Warrant (right to buy)
INSIDER POWER
92.180
Last 77 transactions
Buy: 5 462 087 | Sell: 1 647 978 (Shares)

Based on the 77 latest insides trades, we have calculated the insider power to be positive at a ratio of 92.180.

In total, the insiders bought 5 462 087 and sold 1 647 978 CNTX shares in the last 77 trades.

Click to get the best stock tips daily for free!

About Context Therapeutics Inc.

Context Therapeutics. Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therapeutics, such as anti-estrogen therapies across female hormone-dependent cancers. The company is also dev... CNTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT